Paul E. Berard

Oncology
425 Post Rd
Fairfield, CT 06824

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia.

Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia.

Journal: Allergy & rhinology (Providence, R.I.)
Published: September 09, 2014
Showing 1-1 of 1

Last Updated: 09/26/2026